SCHEMBL5195589

SCHEMBL5195589

CC(C)(C)C/C=C(\NC(=O)OCc1ccccc1)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.50
CA12 O43570 2/20 0.47
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
CA9 Q16790 2/20 0.47
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
LMNA P02545 2/20 0.45
ALDH1A1 P00352 1/20 0.45
CTSL P07711 1/20 0.44
CTSB P07858 1/20 0.44
CTSS P25774 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
SYK P43405 1/20 0.43
POLB P06746 1/20 0.43
HTT P42858 1/20 0.43
MIF P14174 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5195592 1.00 SMN1; SMN2 (0.50) SMN1; SMN2CA12CA1CA2CA9
SCHEMBL5195582 1.00 SMN1; SMN2 (0.50) SMN1; SMN2CA12CA1CA2CA9
SCHEMBL5416978 0.89 SMN1; SMN2 (0.48) SMN1; SMN2CA12CA1CA2CA9
SCHEMBL6349002 0.89 SMN1; SMN2 (0.48) SMN1; SMN2CA12CA1CA2CA9
SCHEMBL5416980 0.89 SMN1; SMN2 (0.48) SMN1; SMN2CA12CA1CA2CA9
SCHEMBL2156827 0.86 MEN1 (0.47) SMN1; SMN2CA12CA1CA2CA9
SCHEMBL2156823 0.86 MEN1 (0.47) SMN1; SMN2CA12CA1CA2CA9
SCHEMBL4245008 0.84 CA12 (0.50) SMN1; SMN2CA12CA1CA2CA9
SCHEMBL4245012 0.84 CA12 (0.50) SMN1; SMN2CA12CA1CA2CA9
SCHEMBL5194570 0.84 CTSS (0.47) SMN1; SMN2CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1812383-A1 GLYCOGEN PHOSPHORYLASE INHIBITOR COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF Smithkline Beecham Corporation (US) 2007-08-01 EP disclosed
WO-2006052722-A1 GLYCOGEN PHOSPHORYLASE INHIBITOR COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF SMITHKLINE BEECHAM CORPORATION (US) 2006-05-18 WO disclosed